1. Home
  2. SLXN vs STKH Comparison

SLXN vs STKH Comparison

Compare SLXN & STKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLXN
  • STKH
  • Stock Information
  • Founded
  • SLXN 2008
  • STKH 2018
  • Country
  • SLXN Israel
  • STKH Israel
  • Employees
  • SLXN N/A
  • STKH N/A
  • Industry
  • SLXN
  • STKH Packaged Foods
  • Sector
  • SLXN
  • STKH Consumer Staples
  • Exchange
  • SLXN NYSE
  • STKH Nasdaq
  • Market Cap
  • SLXN 4.3M
  • STKH 4.9M
  • IPO Year
  • SLXN N/A
  • STKH 2021
  • Fundamental
  • Price
  • SLXN $0.85
  • STKH $0.98
  • Analyst Decision
  • SLXN Strong Buy
  • STKH
  • Analyst Count
  • SLXN 1
  • STKH 0
  • Target Price
  • SLXN $5.00
  • STKH N/A
  • AVG Volume (30 Days)
  • SLXN 955.8K
  • STKH 16.0K
  • Earning Date
  • SLXN 05-21-2025
  • STKH 03-31-2025
  • Dividend Yield
  • SLXN N/A
  • STKH N/A
  • EPS Growth
  • SLXN N/A
  • STKH N/A
  • EPS
  • SLXN N/A
  • STKH N/A
  • Revenue
  • SLXN N/A
  • STKH $10,000.00
  • Revenue This Year
  • SLXN N/A
  • STKH N/A
  • Revenue Next Year
  • SLXN N/A
  • STKH N/A
  • P/E Ratio
  • SLXN N/A
  • STKH N/A
  • Revenue Growth
  • SLXN N/A
  • STKH N/A
  • 52 Week Low
  • SLXN $0.21
  • STKH $0.92
  • 52 Week High
  • SLXN $13.56
  • STKH $5.38
  • Technical
  • Relative Strength Index (RSI)
  • SLXN N/A
  • STKH 27.62
  • Support Level
  • SLXN N/A
  • STKH $0.92
  • Resistance Level
  • SLXN N/A
  • STKH $1.08
  • Average True Range (ATR)
  • SLXN 0.00
  • STKH 0.10
  • MACD
  • SLXN 0.00
  • STKH -0.01
  • Stochastic Oscillator
  • SLXN 0.00
  • STKH 13.42

About SLXN BIOMOTION SCIENCES

Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industries through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

Share on Social Networks: